![]() |
|
|
Vol. 28, Issue 3, 335-338, March 2000
Department of Pediatrics, Kapi'olani Medical Center for Women and
Children and the John A. Burns School of Medicine (L.M.I., N.F.,
K.T.N.); Departments of Pediatrics (M.J.C., D.M.G.) and Clinical
Investigations Laboratory (K.T.N.), Tripler Army Medical Center,
Honolulu, Hawaii; and Mecstat Laboratories, Des Plaines, Illinois
(C.M.M.)
Recently, meta-hydroxybenzoylecgonine
(m-OH BE) was identified by gas chromatography-mass
spectroscopy during quantitative analysis for cocaine.
Identification of m-OH BE in addition to the routinely
identified benzoylecgonine by gas chromatography-mass spectroscopy
confirmatory assays may increase detection of cocaine-exposed infants
and decrease false negative results. However, it is not known whether
m-OH BE is derived directly from benzoylecgonine or from
hydroxylated cocaine, or whether this metabolite is produced in the
fetus or transferred across the placenta from the maternal circulation.
We quantitated the recovery of cocaine, benzoylecgonine, and
m-OH BE from amniotic fluid, fetal meconium, fetal
intestine, and maternal urine for up to 4 days after single dose
administration of either cocaine or benzoylecgonine to pregnant
time-bred guinea pigs. m-OH BE was recovered from
meconium after maternal injections of cocaine and benzoylecgonine.
There was no significant detection of m-OH BE from
amniotic fluid or intestine and minimal recovery from maternal urine
after either cocaine or benzoylecgonine administration. Detection of
m-OH BE in meconium increased the identification of in
utero exposed guinea pigs, and the greatest yield of
m-OH BE from meconium occurred later than that observed
for cocaine or benzoylecgonine.